<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="viewport" content="width=device-width,initial-scale=1"><meta name="robots" content="noindex"><!-- Begin Jekyll SEO tag v2.8.0 --><title>Courses</title><meta name="generator" content="Jekyll v3.9.2"><meta property="og:title" content="Courses"><meta property="og:locale" content="en_US"><meta name="description" content="Lorem ipsum dolor sit amet consectetur adipisicing elit. Natus ipsum cumque officiis nostrum quam maiores tenetur illo placeat expedita et."><meta property="og:description" content="Lorem ipsum dolor sit amet consectetur adipisicing elit. Natus ipsum cumque officiis nostrum quam maiores tenetur illo placeat expedita et."><link rel="canonical" href="https://objectively.github.io/engelberg/courses/"><meta property="og:url" content="https://objectively.github.io/engelberg/courses/"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><meta property="twitter:title" content="Courses"><script type="application/ld+json">{"@context":"https://schema.org","@type":"WebPage","description":"Lorem ipsum dolor sit amet consectetur adipisicing elit. Natus ipsum cumque officiis nostrum quam maiores tenetur illo placeat expedita et.","headline":"Courses","url":"https://objectively.github.io/engelberg/courses/"}</script><!-- End Jekyll SEO tag --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:title" content="Courses"><meta name="twitter:description" content="Lorem ipsum dolor sit amet consectetur adipisicing elit. Natus ipsum cumque officiis nostrum quam maiores tenetur illo placeat expedita et."><title>Courses</title><link rel="shortcut icon" href="/engelberg/images/favicon.ico" type="image/x-icon"><!-- <link rel="stylesheet" href="/engelberg/vendor/styleguide-v2.1.css"> --><link rel="stylesheet" href="/engelberg/vendor/foundation.min.css"><link rel="stylesheet" href="/engelberg/assets/style.min.css"><!-- <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet"> --><link href="https://fonts.googleapis.com/css?family=Material+Icons|Material+Icons+Outlined|Material+Icons+Two+Tone|Material+Icons+Round|Material+Icons+Sharp" rel="stylesheet"><link rel="preconnect" href="https://fonts.googleapis.com"><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link href="https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;700&family=Roboto+Condensed:wght@300;400;700&display=swap" rel="stylesheet"></head><body><a href="/engelberg/courses/#main" class="skip-to-main-content-link">Skip to main content</a><header class="top-bar top-bar--white"><button class="top-bar__menu-button js-trigger-menu js-trigger-menu--left"><span class="menu-button__decorator"></span> <span class="menu-button__text">menu</span></button><div class="top-bar__logo-container"><img class="logo" alt="logo" src="/engelberg/images/circle-logo.svg"></div><nav class="main-nav"><a href="#" class="close-button"><i class="material-icons">close</i></a> <a class="home-button" href="/engelberg/"><i class="material-icons">home</i></a><div class="row expanded"><div class="column large-3 small-12 medium-6 link-column"><span class="header-link header-link--no-hover">Individual Pages</span> <a href="/engelberg/">Index</a> <a href="/engelberg/about">About</a> <a href="/engelberg/what-we-do">What We Do</a> <a href="/engelberg/our-mission">Our Mission</a> <a href="/engelberg/for-students">For Students</a></div><div class="column large-4 small-12 medium-6 link-column"><span class="header-link header-link--no-hover">Template Generated Pages</span><div class="row expanded no-padding"><div class="column large-12"><a href="/engelberg/announcement">Announcement (announcement layout)</a> <a href="/engelberg/event">Event Layout</a> <a href="/engelberg/open-hardware">Topic Layout</a> <a href="/engelberg/profile">Profile Layout</a> <a href="/engelberg/project">Project Layout</a> <a href="/engelberg/team">Generic Layout (Team)</a> <a href="/engelberg/generic">Generic Layout (Generic))</a> <a href="/engelberg/product">Product Layout</a></div></div></div><div class="column large-3 small-12 medium-6 link-column"><span class="header-link header-link--no-hover">Landing Pages</span> <a href="/engelberg/events">Events</a> <a href="/engelberg/projects">Projects</a></div><div class="column large-2 small-12 medium-6 link-column link-column--logo"><span class="header-link header-link--no-hover">List Pages</span> <img class="logo" alt="logo" src="/engelberg/images/circle-logo.svg"></div></div></nav></header><main class="courses-layout" id="main" role="main"><!-- Layout 2 --><div class="row expanded"><div class="column large-4 medium-12 small-12 course-header"><span class="course-type">Courses</span><h1>Innovation Policy Colloquium 2022</h1><span class="course-leaders">Rochelle Dreyfuss and Katherine Strandburg</span><div class="heading-decorator"><div class="decorator"></div></div></div><div class="column large-7 large-offset-1 medium-12 small-12 courses-container"><div class="course"><span class="course__date">Thursday January 27</span> <span class="course__instructor">Siva Thambisetty</span> <span class="course__affiliation">LSE Law School, London School of Economics and Political Science</span><p class="course__description">The TRIPS Intellectual Property Waiver Proposal&#58; Creating the Right Incentives in Patent Law and Politics to end the COVID-19 Pandemic</p><p class="course__abstract">Abstract&#58; Addressing Vaccine Inequity examines global vaccine inequality during the COVID-19 pandemic. We critique intellectual property (IP) law under the 1995 WTO TRIPS Agreement, and specifically, the role that IP plays in enabling the inequities of production, distribution and pricing in the COVID-19 vaccine context. Given the failure of international response mechanisms, including COVAX and C-TAP, to address vaccine inequity, we argue the TRIPS waiver proposal offers a necessary and proportionate legal measure for clearing IP barriers that cannot be achieved by TRIPS flexibilities. Finally, we reflect on the waiver in the wider context of TRIPS, addressing TRIPS' successes and failures. TRIPS Waiver is a work in progress that discusses the plea for TRIPS waiver as a plea for greater degrees of transnational private ordering to emerge to meet public health goals.</p></div><div class="course"><span class="course__date">Thursday January 27</span> <span class="course__instructor">Siva Thambisetty</span> <span class="course__affiliation">LSE Law School, London School of Economics and Political Science</span><p class="course__description">The TRIPS Intellectual Property Waiver Proposal&#58; Creating the Right Incentives in Patent Law and Politics to end the COVID-19 Pandemic</p><p class="course__abstract">Abstract&#58; Addressing Vaccine Inequity examines global vaccine inequality during the COVID-19 pandemic. We critique intellectual property (IP) law under the 1995 WTO TRIPS Agreement, and specifically, the role that IP plays in enabling the inequities of production, distribution and pricing in the COVID-19 vaccine context. Given the failure of international response mechanisms, including COVAX and C-TAP, to address vaccine inequity, we argue the TRIPS waiver proposal offers a necessary and proportionate legal measure for clearing IP barriers that cannot be achieved by TRIPS flexibilities. Finally, we reflect on the waiver in the wider context of TRIPS, addressing TRIPS' successes and failures. TRIPS Waiver is a work in progress that discusses the plea for TRIPS waiver as a plea for greater degrees of transnational private ordering to emerge to meet public health goals.</p></div><div class="course"><span class="course__date">Thursday January 27</span> <span class="course__instructor">Siva Thambisetty</span> <span class="course__affiliation">LSE Law School, London School of Economics and Political Science</span><p class="course__description">The TRIPS Intellectual Property Waiver Proposal&#58; Creating the Right Incentives in Patent Law and Politics to end the COVID-19 Pandemic</p><p class="course__abstract">Abstract&#58; Addressing Vaccine Inequity examines global vaccine inequality during the COVID-19 pandemic. We critique intellectual property (IP) law under the 1995 WTO TRIPS Agreement, and specifically, the role that IP plays in enabling the inequities of production, distribution and pricing in the COVID-19 vaccine context. Given the failure of international response mechanisms, including COVAX and C-TAP, to address vaccine inequity, we argue the TRIPS waiver proposal offers a necessary and proportionate legal measure for clearing IP barriers that cannot be achieved by TRIPS flexibilities. Finally, we reflect on the waiver in the wider context of TRIPS, addressing TRIPS' successes and failures. TRIPS Waiver is a work in progress that discusses the plea for TRIPS waiver as a plea for greater degrees of transnational private ordering to emerge to meet public health goals.</p></div></div></div></main><div id="overlay" class="js-overlay"></div><script src="https://code.jquery.com/jquery-3.4.1.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><script src="/engelberg/assets/bundle.js"></script></body></html>